XENE
Xenon Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $3.28B | Price | $41.92 |
| Volume | 766.09K | Change | -1.76% |
| P/E Ratio | -14.0 | Open | $42.26 |
| Revenue | -- | Prev Close | $42.67 |
| Net Income | $-234.3M | 52W Range | $26.74 - $46.00 |
| Div Yield | N/A | Target | $54.92 |
| Overall | 56 | Value | 55 |
| Quality | 39 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyXenon Pharmaceuticals Inc. (XENE) is a leading Healthcare company in the Biotechnology industry, currently trading at $41.92 with a market capitalization of $3.28 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows XENE with a volume of 766K shares. The stock opened down 0.96% from yesterday's close of $42.67. Current analyst estimates project earnings of $-4.25 per share for this year, with next year targeting $-4.47.
XENE demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including CMRX, ATRA, ATNM, ATHX.
Key investment considerations for XENE include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 31.0%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 04:48 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XENE | $41.92 | -1.8% | 766.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xenon Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW